917568-40-2Relevant academic research and scientific papers
MOENOMYCIN ANALOGS, METHODS OF SYNTHESIS, AND USES THEREOF
-
Page/Page column 158; 160, (2009/05/30)
The present invention provides novel moenomycin analogs as well as pharmaceutical compositions thereof, methods of synthesis, and methods of use in treating an infection by administering an inventive compound to a subject in need thereof. The moenomycin a
Study on systematizing the synthesis of the a-series ganglioside glycans GT1a, GD1a, and GM1 using the newly developed N-Troc-protected GM3 and GalN intermediates
Komori, Tatsuya,Imamura, Akihiro,Ando, Hiromune,Ishida, Hideharu,Kiso, Makoto
experimental part, p. 1453 - 1463 (2009/12/05)
A first systematic synthesis of the glycan parts of the a-series gangliosides (GT1a, GD1a, and GM1) utilizing the newly developed N-Troc-protected GM3 and galactosaminyl building blocks is described. The key processes, including the assembly of the GM2 se
The total synthesis of moenomycin A
Taylor, James G.,Li, Xuechen,Oberthuer, Markus,Zhu, Wenjiang,Kahne, Daniel E.
, p. 15084 - 15085 (2007/10/03)
Moenomycin A is the only known natural antibiotic that inhibits bacterial cell wall synthesis by binding to the transglycosylases that catalyze formation of the carbohydrate chains of peptidoglycan. We report here the total synthesis of moenomycin A using
